Day 1 – Thursday, June 20, 2024
|
Keynote Speech 2024: Phage Therapeutics 2024: The Critical Role of Translational Research in Clinical Trials |
|
|
|
Session 1: Phages, Hosts & Microbiome: On the Way to Medical Revolution |
|
|
|
|
|
|
|
|
|
Session 2 – Phage Therapy: Emerging Trends and Innovative Approaches |
|
|
|
|
 Antonia P. Sagona, University of Warwick, United Kingdom
|
|
|
Robert T. Schooley, University of California, San Diego, USA
Eugene V Koonin, National Institutes of Health, USA
Wolfgang Weninger, Medical University of Vienna, Austria
Jumpei Fujiki, University of California San Diego, USA
Domenico Frezza, University of Roma Tor Vergata, Italy
Graham F. Hatfull, University of Pittsburgh, USA
Paul Turner, Yale University, USA 
Rodrigo Ibarra Chavez, University of Copenhagen, DenmarkDay 2 – Friday, June 21, 2024
|
Session 3: Phages Therapy 2024: From Bench to Bedside |
|
|
 Sabrina Green, KU Leuven, Belgium |
 Federica Briani, University of Milan, Italy |
|
Session 4: Ethical Considerations and Regulatory Landscape of Phage Therapy: Challenges, Advocacy and Task Forces |
|
|
 Jean-Paul Pirnay, Queen Astrid Military Hospital, Belgium
|
 Pieter-Jan Ceyssens, Sciensano, Belgium |
|
Phage Therapy 2024 Concluding Remarks |
|
Phage Therapy 2024 Awards: |
| End of Targeting Phage Therapy 2024 |
Nannan Wu, Shanghai Public Health Clinical Center, Fudan University, China
Barbara Brenner, Kanzlei BRENNER, Germany